Dataset Information


Monoclonal Antibody to Marinobufagenin Downregulates TGF? Profibrotic Signaling in Left Ventricle and Kidney and Reduces Tissue Remodeling in Salt-Sensitive Hypertension.

ABSTRACT: Background Elevated levels of an endogenous Na/K-ATPase inhibitor marinobufagenin accompany salt-sensitive hypertension and are implicated in cardiac fibrosis. Immunoneutralization of marinobufagenin reduces blood pressure in Dahl salt-sensitive (Dahl-S) rats. The effect of the anti-marinobufagenin monoclonal antibody on blood pressure, left ventricular (LV) and renal remodeling, and gene expression were investigated in hypertensive Dahl-S rats. Methods and Results Dahl-S rats were fed high NaCl (8%, HS; n=14) or low NaCl (0.1%, LS; n=14) diets for 8 weeks. Animals were administered control antibody (LS control antibody, LSC; HS control antibody, HSC; n=7 per group) or anti-marinobufagenin antibody once on week 7 of diet intervention (n=7 per group). Levels of marinobufagenin, LV, and kidney mRNAs and proteins implicated in profibrotic signaling were assessed. Systolic blood pressure was elevated (211±8 versus 133±3 mm Hg, P<0.01), marinobufagenin increased 2-fold in plasma (P<0.05) and 5-fold in urine (P<0.01), LV and kidney weights increased, and levels of LV collagen-1 rose 3.5-fold in HSC versus LSC. Anti-marinobufagenin antibody treatment decreased systolic blood pressure by 24 mm Hg (P<0.01) and reduced organ weights and level of LV collagen-1 (P<0.01) in hypertensive Dahl salt-sensitive rats with anti-marinobufagenin antibody versus HSC. The expression of genes related to transforming growth factor-?-dependent signaling was upregulated in the left ventricles and kidneys in HSC versus LSC groups and became downregulated following administration of anti-marinobufagenin antibody to hypertensive Dahl-S rats. Marinobufagenin also activated transforming growth factor-? signaling in cultured ventricular myocytes from Dahl-S rats. Conclusions Immunoneutralization of heightened marinobufagenin levels in hypertensive Dahl-S rats resulted in a downregulation of genes implicated in transforming growth factor-? pathway, which indicates that marinobufagenin is an activator of profibrotic transforming growth factor-?-dependent signaling in salt-sensitive hypertension.


PROVIDER: S-EPMC6818028 | BioStudies | 2019-01-01

REPOSITORIES: biostudies

Similar Datasets

2022-07-12 | GSE208009 | GEO
1000-01-01 | S-EPMC4618091 | BioStudies
2016-01-01 | S-EPMC4834906 | BioStudies
2017-07-27 | GSE92669 | GEO
2010-01-01 | S-EPMC3070381 | BioStudies
| S-EPMC6035785 | BioStudies
| S-EPMC3867812 | BioStudies
2007-01-01 | S-EPMC2013885 | BioStudies
1000-01-01 | S-EPMC5675900 | BioStudies
| S-EPMC2929369 | BioStudies